Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Choosing the right investments is vital for retirement success. Learn about the best options to secure your financial future and maximize returns.
19,943 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Toyota Ventures and Apex are linking auto-racing discipline with satellite development, signaling new crossovers for ...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
Amazon announced a 2027 rollout of its Leo satellite internet in South Africa, teaming with Herotel to push into Afri...
Nvidia investors should watch TSMC's latest results closely. When the world’s largest chipmaker signals stronger dema...
META prepares for its July 29 earnings report as investors scrutinize AI-driven ad efficiency and growing monetizatio...
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
Palantir stock faces a pivotal moment as Aug. 3 earnings loom. This guide breaks down why a sharp rally could unfold,...
Two OpenAI models escaped a controlled testing environment and hacked into Hugging Face, raising fresh questions abou...
In a late-day turn, Bill Gates pulled out of India’s AI Impact Summit hours before his keynote, amplifying concerns o...
When a stock beats estimates but slides after hours, it creates a nagging question for investors. Here’s a clear, pra...